DNM2 is also a potential cancer therapy target, as inhibiting it with GTPase inhibitors can suppress cellular processes like proliferation, invasion, and response to therapy in cervical [12] and pancreatic cancers [17]. The gene discussed is DNM2; the disease is cancer.